We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAIL icon
4101
FreightCar America
RAIL
$243M
$6.51K ﹤0.01%
1,343
TRQ
4102
DELISTED
Turquoise Hill Resources Ltd
TRQ
$6.38K ﹤0.01%
1,343
SZK icon
4103
ProShares UltraShort Consumer Staples
SZK
$9.06M
$6.37K ﹤0.01%
65
-126
-66% -$13K
QHC
4104
DELISTED
Quorum Health Corporation
QHC
$6.35K ﹤0.01%
5,246
NWHM
4105
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$6.29K ﹤0.01%
1,443
HFFG icon
4106
HF Foods Group
HFFG
$99.2M
$6.26K ﹤0.01%
367
+348
+1,832% +$6.9K
NRCG
4107
DELISTED
NRC Group Holdings Corp.
NRCG
$6.25K ﹤0.01%
502
+446
+796% +$5.32K
PROV icon
4108
Provident Financial
PROV
$113M
$6.18K ﹤0.01%
298
-12
-4% -$249
VUZI icon
4109
Vuzix
VUZI
$218M
$6.18K ﹤0.01%
2,711
BH.A icon
4110
Biglari Holdings Class A
BH.A
$1.23B
$6.17K ﹤0.01%
11
AMPE
4111
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$6.13K ﹤0.01%
41
ABUS icon
4112
Arbutus Biopharma
ABUS
$907M
$6.04K ﹤0.01%
3,962
LUMO
4113
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$6.02K ﹤0.01%
421
-12
-3% -$176
ALC icon
4114
Alcon
ALC
$35.6B
$6K ﹤0.01%
103
PFIE
4115
DELISTED
Profire Energy, Inc
PFIE
$5.98K ﹤0.01%
3,166
ACRS icon
4116
Aclaris Therapeutics
ACRS
$860M
$5.96K ﹤0.01%
5,519
+1,525
+38% +$2.16K
PTE
4117
DELISTED
PolarityTE, Inc. Common Stock
PTE
$5.95K ﹤0.01%
74
+1
+1% +$114
MUX icon
4118
McEwen Inc
MUX
$1.18B
$5.87K ﹤0.01%
+376
New +$6.85K
NHTC icon
4119
Natural Health Trends
NHTC
$15.4M
$5.74K ﹤0.01%
811
NL icon
4120
NLI Holdings
NL
$329M
$5.68K ﹤0.01%
1,510
+13
+0.9% +$51
SYBX
4121
DELISTED
Synlogic
SYBX
$5.67K ﹤0.01%
165
+51
+45% +$3.69K
SCPL
4122
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$5.65K ﹤0.01%
+528
New +$5.77K
FSTX
4123
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$5.65K ﹤0.01%
403
EYPT icon
4124
EyePoint Inc
EYPT
$1.17B
$5.54K ﹤0.01%
+306
New +$4.74K
CRVS icon
4125
Corvus Pharmaceuticals
CRVS
$1.27B
$5.44K ﹤0.01%
1,806

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.